Bio-Techne (TECH) Non Operating Income (2009 - 2026)
Bio-Techne's quarterly Non Operating Income came in at -$4.3 million in Q1 2026, down 883.87% year-on-year from $544732.5 in Q1 2025, and down 16.13% quarter-over-quarter from -$3.7 million in Q4 2025.
Bio-Techne has reported Non Operating Income for 18 years, with the latest figure at -$4.3 million in Q1 2026.
- For the quarter ending Q1 2026, Non Operating Income fell 883.87% year-over-year to -$4.3 million; the trailing twelve-month figure through Mar 2026 stood at -$6.6 million (down 291.24% YoY), and the FY2025 full-year result was -$3.8 million, up 55.82% from the prior year.
- Non Operating Income for Q1 2026 stood at -$4.3 million, down from -$3.7 million in the prior quarter.
- The five-year high for Non Operating Income was $47.4 million in Q3 2022, with the low at -$21.7 million in Q1 2022.
- Average Non Operating Income over 5 years is $254823.5, with a median of -$1.5 million recorded in 2022.
- Year-over-year, Non Operating Income soared 1039.13% in 2022 and slumped 39326.67% in 2024.
- Tracing TECH's Non Operating Income over 5 years: stood at -$1.5 million in 2022, then plunged by 215.8% to -$4.6 million in 2023, then increased by 1.6% to -$4.5 million in 2024, then gained by 19.06% to -$3.7 million in 2025, then slipped by 16.13% to -$4.3 million in 2026.
- The last three Non Operating Income figures came in at -$4.3 million (Q1 2026), -$3.7 million (Q4 2025), and $333000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 444,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 201.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -46.98 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | -4.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.27 Mn |
| Dec 31, 2025 | -3.68 Mn |
| Sep 30, 2025 | 333,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | -434,000.00 |
| Dec 31, 2024 | -4.54 Mn |
| Sep 30, 2024 | 184,000.00 |
| Jun 30, 2024 | 8.25 Mn |
| Mar 31, 2024 | -5.91 Mn |
| Dec 31, 2023 | -4.62 Mn |
| Sep 30, 2023 | -6.30 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | -15,000.00 |
| Dec 31, 2022 | -1.46 Mn |
| Sep 30, 2022 | 47.40 Mn |
| Jun 30, 2022 | -1.52 Mn |
| Mar 31, 2022 | -21.68 Mn |
| Dec 31, 2021 | 23.83 Mn |
| Sep 30, 2021 | 4.16 Mn |
| Jun 30, 2021 | -61.47 Mn |
| Mar 31, 2021 | -20.73 Mn |
| Dec 31, 2020 | 8.88 Mn |
| Sep 30, 2020 | -5.45 Mn |
| Jun 30, 2020 | 26.71 Mn |
| Mar 31, 2020 | -970,000.00 |
| Dec 31, 2019 | 113.33 Mn |
| Sep 30, 2019 | -10.41 Mn |
| Jun 30, 2019 | 658,000.00 |
| Mar 31, 2019 | 10.82 Mn |
| Dec 31, 2018 | -6.19 Mn |
| Sep 30, 2018 | -3.04 Mn |
| Jun 30, 2018 | 13.36 Mn |
| Mar 31, 2018 | -18.10 Mn |
| Dec 31, 2017 | -154,000.00 |
| Sep 30, 2017 | -3.06 Mn |
| Jun 30, 2017 | -360,000.00 |
| Mar 31, 2017 | -326,000.00 |
| Dec 31, 2016 | -2.61 Mn |
| Sep 30, 2016 | -20,000.00 |
| Jun 30, 2016 | -1.87 Mn |
| Mar 31, 2016 | -654,000.00 |
| Dec 31, 2015 | -651,000.00 |
| Sep 30, 2015 | 818,000.00 |
| Jun 30, 2015 | -10.05 Mn |
| Mar 31, 2015 | -411,000.00 |
| Dec 31, 2014 | -51,000.00 |
| Sep 30, 2014 | -492,000.00 |
| Jun 30, 2014 | -1.12 Mn |
| Mar 31, 2014 | 300,000.00 |
| Dec 31, 2013 | 474,000.00 |
| Sep 30, 2013 | 263,000.00 |
| Jun 30, 2013 | 948,000.00 |
| Mar 31, 2013 | 520,000.00 |
| Dec 31, 2012 | -135,000.00 |
| Sep 30, 2012 | -478,000.00 |
| Jun 30, 2012 | -601,000.00 |
| Mar 31, 2012 | -3.16 Mn |
| Dec 31, 2011 | 191,000.00 |
| Sep 30, 2011 | -447,000.00 |
| Jun 30, 2011 | 368,000.00 |
| Mar 31, 2011 | 646,000.00 |
| Dec 31, 2010 | -698,000.00 |
| Sep 30, 2010 | -257,000.00 |
| Jun 30, 2010 | -324,000.00 |
| Mar 31, 2010 | -1.25 Mn |
| Dec 31, 2009 | 145,000.00 |
| Sep 30, 2009 | 506,000.00 |